![]() |
JOURNAL TOOLS |
Publishing options |
eTOC |
To subscribe |
Recommend to your librarian |
ARTICLE TOOLS |
Publication history |
Reprints |
Permissions |
Cite this article as |
Share |


YOUR ACCOUNT
YOUR ORDERS
SHOPPING BASKET
Items: 0
Total amount: € 0,00
HOW TO ORDER
YOUR SUBSCRIPTIONS
YOUR ARTICLES
YOUR EBOOKS
COUPON
ACCESSIBILITY
REVIEW NON-INVASIVE RESPIRATORY SUPPORT IN COVID-19 PNEUMONIA Open access
Italian Journal of Emergency Medicine 2021 December;10(3):123-7
DOI: 10.23736/S2532-1285.21.00115-4
Copyright © 2021 THE AUTHORS
This is an open access article distributed under the terms of the CC BY-NC-ND 4.0 license which allows users to copy and distribute the manuscript, as long as this is not done for commercial purposes and further does not permit distribution of the manuscript if it is changed or edited in any way, and as long as the user gives appropriate credits to the original author(s) and the source (with a link to the formal publication through the relevant DOI) and provides a link to the license.
language: English
The role of high-flow nasal cannulae oxygenation
Stefano DE VUONO, Maria R. TALIANI, Sokol BERISHA, Pasquale CIANCI, Alessandra LIGNANI, Francesco BALDUCCI, Laura SETTIMI, Giorgia MANINA, Paolo GROFF ✉
Emergency Department, Santa Maria della Misericordia Hospital, Perugia, Italy
Since December 2019, COVID-19 pandemic has reached unprecedented proportions putting a strain on health systems, governments and society as a whole. Regarding the health problem, about 3-5% of people affected by the disease need hospitalization in intensive care unit (ICU). This resulted in a severe shortage of ICU beds, ventilators, drugs and staff in many countries; nevertheless, the evidence for efficacy of these interventions is yet to be consolidated. Consequently more attention has focused on non-invasive respiratory support techniques, both as a potential tool for preventing ICU admission in patients with evolving acute respiratory failure, and as a possible alternative to conventional ventilation in the context of restraint in ICU resources. High-flow oxygen therapy has been shown to be useful in the treatment of acute hypoxemic respiratory failure of various etiology already in the pre-COVID era and has been widely used, with various results, during the pandemic. Its usefulness may derive from the ease of use, its low cost and its mechanism of action which may correspond to some phases of the pathophysiology of the COVID-related disease. In this article we present a summary of the literature available in order to provide the emergency physician with elements to evaluate the pros and cons of its use in the particular context of the emergency department.
KEY WORDS: COVID-19; Pneumonia; Cannula; Non-invasive ventilation